Annual Cash & Cash Equivalents:
$94.82M-$130.13M(-57.85%)Summary
- As of today, TARS annual cash & cash equivalents is $94.82 million, with the most recent change of -$130.13 million (-57.85%) on December 31, 2024.
- During the last 3 years, TARS annual cash & cash equivalents has fallen by -$76.51 million (-44.66%).
- TARS annual cash & cash equivalents is now -57.85% below its all-time high of $224.95 million, reached on December 31, 2023.
Performance
TARS Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$381.14M-$26.77M(-6.56%)Summary
- As of today, TARS quarterly cash & cash equivalents is $381.14 million, with the most recent change of -$26.77 million (-6.56%) on June 30, 2025.
- Over the past year, TARS quarterly cash & cash equivalents has increased by +$57.56 million (+17.79%).
- TARS quarterly cash & cash equivalents is now -6.56% below its all-time high of $407.92 million, reached on March 31, 2025.
Performance
TARS Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TARS Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -57.9% | +17.8% |
| 3Y3 Years | -44.7% | +55.3% |
| 5Y5 Years | +63.6% | +617.3% |
TARS Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -57.9% | +32.3% | -6.6% | +113.8% |
| 5Y | 5-Year | -57.9% | +63.6% | -6.6% | +341.4% |
| All-Time | All-Time | -57.9% | +3926.3% | -6.6% | +617.3% |
TARS Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $381.14M(-6.6%) |
| Mar 2025 | - | $407.92M(+40.0%) |
| Dec 2024 | $94.82M(-57.8%) | $291.38M(-8.1%) |
| Sep 2024 | - | $316.95M(-2.0%) |
| Jun 2024 | - | $323.58M(+8.4%) |
| Mar 2024 | - | $298.52M(+31.3%) |
| Dec 2023 | $224.95M(+213.9%) | $227.44M(-7.9%) |
| Sep 2023 | - | $246.88M(+38.5%) |
| Jun 2023 | - | $178.23M(-11.4%) |
| Mar 2023 | - | $201.22M(-7.3%) |
| Dec 2022 | $71.66M | $217.03M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $226.57M(-7.7%) |
| Jun 2022 | - | $245.36M(+40.0%) |
| Mar 2022 | - | $175.30M(+2.0%) |
| Dec 2021 | $171.33M(+1.9%) | $171.81M(-6.5%) |
| Sep 2021 | - | $183.80M(+4.0%) |
| Jun 2021 | - | $176.74M(+13.1%) |
| Mar 2021 | - | $156.20M(-7.1%) |
| Dec 2020 | $168.13M(+190.1%) | $168.15M(+94.7%) |
| Sep 2020 | - | $86.35M(+62.5%) |
| Jun 2020 | - | $53.13M(-8.3%) |
| Dec 2019 | $57.95M(+2360.8%) | $57.95M |
| Dec 2018 | $2.35M | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of TARS is $94.82M
What is the all-time high annual cash & cash equivalents for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $224.95M
What is Tarsus Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, TARS annual cash & cash equivalents has changed by -$130.13M (-57.85%)
What is Tarsus Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TARS is $381.14M
What is the all-time high quarterly cash & cash equivalents for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $407.92M
What is Tarsus Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, TARS quarterly cash & cash equivalents has changed by +$57.56M (+17.79%)